Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory N Gan

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cancer Letters|April 4, 2025
MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasisDeri Morgan, Dakota Dd Okwuone, Kiersten L Berggren, et al.
The Lancet. Oncology|June 29, 2026
Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation OncologyJulian Biau, Arnaud Beddok, Manju Sharma, et al.
Molecular Cancer Therapeutics|July 23, 2013
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomasRyan T Anderson, Stephen B Keysar, Daniel W Bowles, et al.
Cancer Research|April 12, 2013
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancerStephen B Keysar, Phuong N Le, Ryan T Anderson, et al.
Science Advances|September 28, 2022
Microfluidic affinity selection of active SARS-CoV-2 virus particlesSachindra S T Gamage, Thilanga N Pahattuge, Harshani Wijerathne, et al.
Nature Reviews. Drug Discovery|February 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Nature Reviews. Drug Discovery|March 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cancer Letters|April 4, 2025
MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasisDeri Morgan, Dakota Dd Okwuone, Kiersten L Berggren, et al.
The Lancet. Oncology|June 29, 2026
Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation OncologyJulian Biau, Arnaud Beddok, Manju Sharma, et al.
Molecular Cancer Therapeutics|July 23, 2013
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomasRyan T Anderson, Stephen B Keysar, Daniel W Bowles, et al.
Cancer Research|April 12, 2013
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancerStephen B Keysar, Phuong N Le, Ryan T Anderson, et al.
Science Advances|September 28, 2022
Microfluidic affinity selection of active SARS-CoV-2 virus particlesSachindra S T Gamage, Thilanga N Pahattuge, Harshani Wijerathne, et al.
Nature Reviews. Drug Discovery|February 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Nature Reviews. Drug Discovery|March 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Pageof 5